← Leaderboards
Kim Green
University Of California-Irvine
$36,308,762
Attributed
$47,222,596
Total exposure
10
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $19.9M · FY2014–25$20M$15M$10M$5M$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$84,066,940 · 11
By mechanism
U54$59,488,226 · 3
U01$10,898,840 · 1
R01$7,017,476 · 3
RF1$5,057,214 · 2
P50$897,866 · 1
T32$707,318 · 1
Top collaborators
- Marcelo Andres Wood5 shared
- Frank M Laferla4 shared
- Thomas E Lane4 shared
- Eran A Mukamel4 shared
- Wei Xu4 shared
- Xiangmin Xu4 shared
- Andrea Joan Tenner3 shared
- Daniele Piomelli2 shared
Most similar at University Of California-Irvine
Same institution · by research overlap
- Xiangmin Xu$44,991,808
- Michael A Yassa$21,614,052
- Hamid Moradi$185,622
- Matthew Everett Griffin$1,711,019
- Mathew Mark Blurton-Jones$14,315,430
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposS DiseaseMouse ModelBrainCellsPathologyGene ExpressionTissuesSynapsesS Disease ModelAgingResponsePhenotypeAmyloid Beta-ProteinCognitionMicrogliaDisease ProgressionNeuronsAdultSignal TransductionLate Onset Alzheimer DiseaseBehavioralInvestigationMorphology
Grant awards (38)
UC Irvine MODEL-AD$9,281,325
U54 · FY2025 · AG
Disease Model Development and Phenotyping Project$5,590,598
U54 · FY2025 · AG · contact PI
Cell-type-specific neural circuit connectomes in the mouse models of aging and Alzheimer's disease$2,591,567
U01 · FY2025 · AG
Role of Disease-Associated Microglia in Alzheimer's disease$763,997
R01 · FY2025 · AG · contact PI
Origins, properties, and therapeutic potential of cells that repopulate the microglia-depleted adult brain$711,565
R01 · FY2025 · NS · contact PI
Neuroimmunology Training Program at the University of California, Irvine$200,556
T32 · FY2025 · NS
UC Irvine MODEL-AD$9,263,803
U54 · FY2024 · AG
Disease Model Development and Phenotyping Project$5,733,814
U54 · FY2024 · AG · contact PI
Cell-type-specific neural circuit connectomes in the mouse models of aging and Alzheimer's disease$2,650,917
U01 · FY2024 · AG
Role of Disease-Associated Microglia in Alzheimer's disease$779,590
R01 · FY2024 · AG · contact PI
Origins, properties, and therapeutic potential of cells that repopulate the microglia-depleted adult brain$715,019
R01 · FY2024 · NS · contact PI
The lipid amidase NAAA as a therapeutic target for Alzheimer's disease$575,906
R01 · FY2024 · AG
Neuroimmunology Training Program at the University of California, Irvine$188,956
T32 · FY2024 · NS
UC Irvine MODEL-AD$9,231,507
U54 · FY2023 · AG
Disease Model Development and Phenotyping Project$5,701,518
U54 · FY2023 · AG · contact PI
Cell-type-specific neural circuit connectomes in the mouse models of aging and Alzheimer's disease$2,644,061
U01 · FY2023 · AG
Origins, properties, and therapeutic potential of cells that repopulate the microglia-depleted adult brain$373,512
R01 · FY2023 · NS · contact PI
Neuroimmunology Training Program at the University of California, Irvine$199,590
T32 · FY2023 · NS
UC Irvine MODEL-AD$9,067,709
U54 · FY2022 · AG
Disease Model Development and Phenotyping Project$5,617,952
U54 · FY2022 · AG · contact PI
Cell-type-specific neural circuit connectomes in the mouse models of aging and Alzheimer's disease$3,012,295
U01 · FY2022 · AG
Origins, properties, and therapeutic potential of cells that repopulate the microglia-depleted adult brain$373,512
R01 · FY2022 · NS · contact PI
Neuroimmunology Training Program at the University of California, Irvine$118,216
T32 · FY2022 · NS
Origins, properties, and therapeutic potential of cells that repopulate the microglia-depleted adult brain$373,512
R01 · FY2021 · NS · contact PI
The lipid amidase NAAA as a therapeutic target for Alzheimer's disease$2,328,624
RF1 · FY2020 · AG
Origins, properties, and therapeutic potential of cells that repopulate the microglia-depleted adult brain$373,512
R01 · FY2020 · NS · contact PI
Origins, properties, and therapeutic potential of cells that repopulate the microglia-depleted adult brain$373,512
R01 · FY2019 · NS · contact PI
Microglia as Mediators of Dendritic Spine Loss and Plaque Formation in the AD Brain$178,117
P50 · FY2019 · AG · contact PI
Microglia are necessary for cortical plaque formation in Alzheimer's disease$2,728,590
RF1 · FY2018 · AG · contact PI
Origins, properties, and therapeutic potential of cells that repopulate the micro$318,761
R01 · FY2018 · NS · contact PI
Microglia as Mediators of Dendritic Spine Loss and Plaque Formation in the AD Brain$178,117
P50 · FY2018 · AG · contact PI
Origins, properties, and therapeutic potential of cells that repopulate the micro$319,848
R01 · FY2017 · NS · contact PI
Microglia as Mediators of Dendritic Spine Loss and Plaque Formation in the AD Brain$178,115
P50 · FY2017 · AG · contact PI
Origins, properties, and therapeutic potential of cells that repopulate the micro$320,874
R01 · FY2016 · NS · contact PI
Microglia as Mediators of Dendritic Spine Loss and Plaque Formation in the AD Brain$178,117
P50 · FY2016 · AG · contact PI
Origins, properties, and therapeutic potential of cells that repopulate the micro$321,841
R01 · FY2015 · NS · contact PI
Microglia as Mediators of Dendritic Spine Loss and Plaque Formation in the AD Brain$185,400
P50 · FY2015 · AG · contact PI
Origins, properties, and therapeutic potential of cells that repopulate the micro$322,515
R01 · FY2014 · NS · contact PI